The trademark application XGene Pharmaceutical was filed by XGENE PHARMACEUTICAL INC., a corporation established under the laws of the Cayman Islands (the "Applicant"). The application was published for oppositions on June 14, 2021, and it was registered by office on September 21, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Vaccines
Medicines for human purposes
Pharmaceutical preparations for the treatment of viral diseases
Pharmaceutical products for the treatment of cancer
Biological preparations for the treatment of cancer
Pain relief medication
Biological preparations for medical purposes
Antibiotics
Protein supplements
Chemico-pharmaceutical preparations
Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Pharmaceutical preparations for treating skin disorders
Dermatological pharmaceutical products
Nutritional supplements
Vitamin supplement patches
Herbicide for agricultural use
Pesticides for agricultural use
Fungicides for agricultural use
Medicines for veterinary purposes.
The mark was filed in class 42 with following description of goods:
Chemical research
Chemical analysis
Chemistry consultation
Cosmetic research
Biological research
Bacteriological research
Conducting technical project studies
Clinical trials
Scientific laboratory services
Scientific research
Scientific research and development
Research and development of new products for others
Medical research
Technological research in the field of medical instruments
Product quality testing
Scientific research for medical purposes in the area of cancerous diseases.